Takeyoshi Yamashita
Chief Tech/Sci/R&D Officer en KYOWA KIRIN CO. LTD. .
Perfil
Takeyoshi Yamashita currently works at Kyowa Kirin Co., Ltd., as Director & Chief Medical Officer from 2023 and Orchard Therapeutics Plc, as Director from 2024.
Cargos activos de Takeyoshi Yamashita
| Empresas | Cargo | Inicio |
|---|---|---|
| KYOWA KIRIN CO. LTD. | Chief Tech/Sci/R&D Officer | 01/04/2023 |
| ORCHARD THERAPEUTICS PLC | Director/Board Member | 24/01/2024 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| KYOWA KIRIN CO. LTD. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Orchard Therapeutics Plc
 Orchard Therapeutics Plc Pharmaceuticals: MajorHealth Technology Orchard Therapeutics Plc is a biopharmaceutical company, which engages in discovering, acquiring, developing and commercializing gene therapies for patients with rare disorders. The company focuses on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, a commercial-stage gamma retroviral-based product for the treatment of Adenosine deaminase deficiency (ADA-SCID). The company was founded by Nicolas Koebel and Andrea Spezzi in August 2018 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Takeyoshi Yamashita
